Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung Man Ho

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Vaccines|July 27, 2024
Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide StudyWang-Chun Kwok, David Christopher Lung, Terence Chi-Chun Tam, et al.
Respiratory Research|February 15, 2023
Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong KongWang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2024
Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programmingYap-Hang Chan, Cheng Yuen-Ting, Chun-Fung Sin, et al.
Respirology (Carlton, Vic.)|June 5, 2013
Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong KongPhilip J Thompson, Sundeep Salvi, Jiangtao Lin, et al.
Respiratory Medicine|September 12, 2020
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemicKing Pui Florence Chan, Ting Fung Ma, Wang Chun Kwok, et al.
Annals of the American Thoracic Society|February 26, 2021
Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 PandemicKing-Pui Florence Chan, Wang-Chun Kwok, Ting-Fung Ma, et al.
Lung|August 10, 2013
Treatment outcomes in elderly with advanced-stage non-small cell lung cancerTerence Chi-Chun Tam, James Chung-Man Ho, Matthew King-Yan Wong, et al.
Drug Safety|August 8, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary PanelJoanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho, et al.
JTO Clinical and Research Reports|February 24, 2026
Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE StudyMyung-Ju Ahn, Daniel Sw Tan, Morgan Windsor, et al.
Investigational New Drugs|November 10, 2025
A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitorsHoi Wai Chan, Chris Chun Long Tse, Yu-Chung Li, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Vaccines|July 27, 2024
Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide StudyWang-Chun Kwok, David Christopher Lung, Terence Chi-Chun Tam, et al.
Respiratory Research|February 15, 2023
Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong KongWang Chun Kwok, Terence Chi Chun Tam, David Chi Leung Lam, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2024
Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programmingYap-Hang Chan, Cheng Yuen-Ting, Chun-Fung Sin, et al.
Respirology (Carlton, Vic.)|June 5, 2013
Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong KongPhilip J Thompson, Sundeep Salvi, Jiangtao Lin, et al.
Respiratory Medicine|September 12, 2020
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemicKing Pui Florence Chan, Ting Fung Ma, Wang Chun Kwok, et al.
Annals of the American Thoracic Society|February 26, 2021
Territory-Wide Study on Hospital Admissions for Asthma Exacerbations in the COVID-19 PandemicKing-Pui Florence Chan, Wang-Chun Kwok, Ting-Fung Ma, et al.
Lung|August 10, 2013
Treatment outcomes in elderly with advanced-stage non-small cell lung cancerTerence Chi-Chun Tam, James Chung-Man Ho, Matthew King-Yan Wong, et al.
Drug Safety|August 8, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary PanelJoanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho, et al.
JTO Clinical and Research Reports|February 24, 2026
Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE StudyMyung-Ju Ahn, Daniel Sw Tan, Morgan Windsor, et al.
Investigational New Drugs|November 10, 2025
A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitorsHoi Wai Chan, Chris Chun Long Tse, Yu-Chung Li, et al.
Pageof 12